Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLCL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGKC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AQP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM217A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100420758 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPNPEP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEATR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on